000 01094 a2200301 4500
005 20250512195624.0
264 0 _c19820719
008 198207s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(82)92357-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDonn, S M
245 0 0 _aPhenobarbitone and neonatal intraventricular haemorrhage.
_h[electronic resource]
260 _bLancet (London, England)
_cMay 1982
300 _a1240-1 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Letter
650 0 4 _aCerebral Hemorrhage
_xprevention & control
650 0 4 _aCerebral Ventricles
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aInfant, Newborn, Diseases
_xprevention & control
650 0 4 _aPhenobarbital
_xtherapeutic use
700 1 _aRoloff, D W
700 1 _aGoldstein, G W
773 0 _tLancet (London, England)
_gvol. 1
_gno. 8283
_gp. 1240-1
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(82)92357-1
_zAvailable from publisher's website
999 _c6123075
_d6123075